Hospital-Acquired Pneumonia Prevention, Implementation, Education, and Research — oral care as frontline prevention.

The Problem

NVHAP is the #1 hospital-acquired infection in the U.S. — yet most hospitals do not track it, do not supply effective oral care products, and have no prevention program. 1 in 100 hospitalized patients develops NVHAP; 1 in 14 hospital deaths is linked to it (Jones et al., 2023). NVHAP adds 13 days to hospital stay, drives 30–50% of all sepsis cases, and costs an estimated $2 billion annually (Munro et al., 2021). The mechanism is clear: within 48 hours of admission the oral microbiome shifts toward pathogenic organisms microaspirated into the lung — making oral hygiene the most actionable prevention target.

The Model: HAPPIER

HAPPIER is an interprofessional evidence-based program built on three drivers: (1) reducing oropharyngeal colonization through comprehensive oral hygiene; (2) reducing microaspiration via head-of-bed elevation, feeding tube care, and swallow screening; (3) strengthening host defenses through early mobility, glycemic control, and immunization. Implementation applies PDSA cycles, IHI Care Bundles, and a “4 Ps” framework (People, Processes, Performance, Products). All adult inpatients should be considered at risk; stratification has not proven feasible across 72+ variables in 133 VA hospitals (Baker & Quinn, 2018).

Key Outcomes and Evidence

Giuliano, Penoyer, Middleton & Baker (AJN, 2021) — 8,709-patient cluster RCT at Orlando Health: 85% NVHAP reduction on medical units, 56% on surgical units using an ADA-approved protocol. Oral care kits had to be provided by the study sponsor — the hospital did not stock them. // Mitchell et al. (Lancet Infectious Diseases, 2026) — HAPPEN trial, largest multi-center RCT in this field: 8,870 patients, 3 Australian hospitals, 60% NVHAP reduction with toothbrush + education at admission. // Nishi et al. (Journal of Hospital Infection, 2026) — propensity-matched cohort, 13,995 inpatients, Hiroshima University Hospital: oral self-care promotion linked to 46% less HAP, 66% less bacteraemia, 34% less UTI — among the first studies to extend oral hygiene evidence to bacteraemia and UTI. // Kaiser Permanente KPNC (Lacerna et al., 2020) — 21 hospitals: 70% HAP rate reduction, major antibiotic stewardship gains. // Kluberg et al. (2025) — 144 hospitals, 1.74M hospitalizations: oral care ≥3 days → 16% less NVHAP, 6% lower mortality; walking ≥3 days → 18% less NVHAP, 80% lower mortality (PMID 40985932). // National modeling: 50% reduction = 53,000 lives + $3.4B saved annually (Munro et al., 2021).

Implementation Science, Interprofessional Teams, and the Role of a Champion

Education alone never sustains change. Durable NVHAP prevention requires a structured implementation science approach (Fixsen et al., 2005; Eccles & Mittman, 2006): gap analysis, theory-based behavior change (Grenny et al.’s Influencer framework), IHI Care Bundles, EHR-embedded oral care workflows, and unit-level compliance feedback. A dedicated champion — CNS, infection preventionist, or QI nurse with physician partnership — is essential to launch, sustain momentum, and prevent programs from stalling after initial education. Critically, NVHAP prevention requires medicine and dentistry to share clinical accountability for the same patient outcome. Oral pathogens are respiratory pathogens; the mouth cannot remain outside acute care. Every successful program — the Giuliano-Baker RCT, Kaiser KPNC, and the Australian HAPPEN trial — was built on an interprofessional foundation where nurses, physicians, infection preventionists, and oral health professionals functioned as co-owners. Joint clinical guidance, shared EHR documentation, and interprofessional training are not optional — they are the architecture of durable prevention.

Persistent Challenges

Two gaps constrain progress: (1) Supply and compliance — most hospitals do not provide effective oral care supplies or track oral care compliance, making prevention practically impossible before documentation is even considered. (2) Surveillance — no universally accepted NVHAP definition limits benchmarking and research. Jones et al. (2023) published a validated EHR-based surveillance algorithm across 284 U.S. hospitals; a free extraction toolkit is available at jamanetwork.com/journals/jamanetworkopen/fullarticle/2805014

National and International Recognition

The Joint Commission issued a Patient Safety Alert (2021); CDC released its Oral Health in Healthcare Settings Toolkit (2024); 2026 CMS Age-Friendly Requirements align pneumonia prevention with sepsis and mobility standards; VA launched the HAPPEN project; APIC issued a position statement. NOHAP coordinated national efforts for two years. Internationally, the HAPPEN trial (Mitchell et al., 2026) and the Hiroshima study (Nishi et al., 2026) have established a global evidence base demonstrating that simple oral self-care promotion reduces HAP, bacteraemia, and UTI across diverse health systems. The evidence no longer requires further proof of concept — it demands action.

Key sources

1. 1Baker, D., & Quinn, B. (2018). HAPPI-2: Incidence of NVHAP. Am J Infect Control, 46(1), 2–7.
2. 2Eccles, M.P., & Mittman, B.S. (2006). Welcome to implementation science. Implementation Science, 1(1).
3. 3Fixsen, D.L., et al. (2005). Implementation research: A synthesis of the literature. U. of South Florida.
4. 4Giuliano, K.K., Penoyer, D., Middleton, A., & Baker, D. (2021). Oral care as prevention for NVHAP: A four-unit cluster RCT. AJN, 121(6), 24–33. PMID: 33993136.
5. 5Grenny, J., et al. (2013). Influencer: The power to change anything. McGraw-Hill.
6. 6Jones, B.E., Sarvet, A.L., Ying, J., Klompas, M., et al. (2023). Incidence and outcomes of NVHAP in 284 US hospitals. JAMA Network Open, 6(5), e2314185.
7. 7Kluberg, S.A., Baker, D., Giuliano, K., Klompas, M., et al. (2025). Oral care and mobility with NVHAP. Infect Control Hosp Epidemiol, 46(12), 1181–1189. PMID: 40985932.
8. 8Lacerna, C.C., et al. (2020). Preventing NVHAP in a large hospital system. Infect Control Hosp Epidemiol, 41(5), 547–552.
9. 9Mitchell, B.G., et al. (2026). The HAPPEN randomised controlled trial. Lancet Infectious Diseases. doi:10.1016/j.jinf.2026.05.029
10. 10Munro, S.C., et al. (2021). NVHAP: A call to action. Infect Control Hosp Epidemiol, 42(8), 991–996.
11. 11Nishi, H., Kawaguchi, H., Ide, N., et al. (2026). Oral self-care promotion and hospital-acquired infections. J Hosp Infect. doi:10.1016/j.jhin.2026.05.029
12. 12Resar, R., et al. (2012). Using care bundles to improve health care quality. IHI Innovation Series White Paper.